Increasing Gap Junctional Coupling: A Tool for Dissecting the Role of Gap Junctions |
| |
Authors: | Lene Nygaard Axelsen Ketil Haugan Martin Stahlhut Anne-Louise Kjølbye James K. Hennan Niels-Henrik Holstein-Rathlou Jørgen Søberg Petersen Morten Schak Nielsen |
| |
Affiliation: | (1) Zealand Pharma A/S, 2600 Glostrup, Denmark;(2) Department of Cardiology, Bispebjerg Hospital, 2200 Copenhagen N, Denmark;(3) Cardiovascular and Metabolic Disease Research, Wyeth Research, Collegeville, PA, USA;(4) Danish National Research Foundation Centre for Cardiac Arrhythmia at Department of Biomedical Sciences, University of Copenhagen, Blegdamsvej 3, Building 10.5, DK-2200 Copenhagen N, Denmark |
| |
Abstract: | Much of our current knowledge about the physiological and pathophysiological role of gap junctions is based on experiments where coupling has been reduced by either chemical agents or genetic modification. This has brought evidence that gap junctions are important in many physiological processes. In a number of cases, gap junctions have been implicated in the initiation and progress of disease, and experimental uncoupling has been used to investigate the exact role of coupling. The inverse approach, i.e., to increase coupling, has become possible in recent years and represents a new way of testing the role of gap junctions. The aim of this review is to summarize the current knowledge obtained with agents that selectively increase gap junctional intercellular coupling. Two approaches will be reviewed: increasing coupling by the use of antiarrhythmic peptide and its synthetic analogs and by interfering with the gating of gap junctional channels. |
| |
Keywords: | Gap junction Connexin – Antiarrhythmic peptide Arrhythmia – Infarct size Osteopenia – Connexin gating – RXP-E |
本文献已被 PubMed SpringerLink 等数据库收录! |
|